Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
(NASDAQ:CPRX),(NASDAQ:XLO), CORAL GABLES, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today announced the appointment of Daniel Curran, MD, to its Board of Directors. Dr. Curran is a distinguished pharmaceutical executive with over 25 years of experience spanning strategy, business development, project leadership, and development. Since March 2024, […]